{"id":2752,"date":"2024-05-27T14:47:01","date_gmt":"2024-05-27T06:47:01","guid":{"rendered":"https:\/\/opentrons.com.cn\/?post_type=knowledge2&p=2752"},"modified":"2024-09-03T17:47:36","modified_gmt":"2024-09-03T09:47:36","slug":"opentrons-elisa","status":"publish","type":"knowledge2","link":"https:\/\/en.opentrons.com.cn\/knowledge2\/opentrons-elisa\/","title":{"rendered":"Automated Elisa (enzyme-linked immunosorbent assay) using Opentrons pipetting workstations"},"content":{"rendered":"\n
Introduction<\/strong> ELISA (enzyme-linked immunosorbent assay) is an important test method widely used in diagnostics and research. In this technology, ensuring consistency in sample processing is critical, and reducing hands-on time can effectively reduce human error. We developed and tested multiple automation protocols using Opentrons OT-2 and Flex liquid handling workstations. These automated protocols allow you to perform experiments directly using ELISA kits, or you can customize specific experimental procedures according to your needs.<\/p>\n\n\n\n Method<\/strong><\/p>\n\n\n\n Kit: Takara Fibronectin (FN) EIA Kit (sandwich ELISA, Figure 1)<\/p>\n\n\n\n Detection method: Tecan Cortisol Saliva ELISA Kit (competition ELISA, Figure 2)<\/p>\n\n\n\n <\/p>\n\n\n\n Detection: Assay method development for cytokine detection (sandwich ELISA, Figure 5) Instrument: Opentrons Flex Workflow: 1. ELISA plate preparation 2. Washing 3. Adding sample (target capture) 4. Washing 5. Adding enzyme-labeled antibody 6. Washing 7. Adding substrate to develop color<\/p>\n\n\n\n Results<\/strong><\/p>\n\n\n\n Figure 6. Takara Fibronectin (FN) EIA Kit (Figure 1). The FN sample was gradient diluted and tested. The test results are as shown in the figure: the left picture shows the FN sample concentration and average absorbance (n=3) data, showing a highly linear regression; the right picture shows the results of three repeated experiments, showing good repeatability. sex and stability.<\/p>\n\n\n\n Figure 7. Tecan Cortisol Saliva ELISA Kit (Figure 2). The cortisol sample was gradient diluted and tested. The test results are as shown in the figure: The left picture shows the cortisol sample concentration and average absorbance (n=3) data, showing a highly linear regression; the right picture shows the results of three repeated experiments, which are well presented. repeatability and stability.<\/p>\n\n\n\n Figure 8. Cell Sciences SARS-CoV-2 Surrogate (Figure 3). The test results show that the positive human serum sample (the ELISA test result that has been previously certified by the FDA is positive) shows a positive result in this test (inhibition rate >20%, calculation formula: inhibition rate = [1 - (sample OD450 value\/OD value of negative control)] x 100%, n = 3).<\/p>\n\n\n\n Figure 9. SARS-CoV-2 Spike RBD-coupled Magnetic Beads (Figure 4). Recombinant neutralizing antibody samples were serially diluted and tested. Test results show that positive human serum samples, previously tested positive in an FDA-cleared ELISA assay, tested positive in this test (n = 3) (right).<\/p>\n\n\n\n Figure 10. Assay Development for Cytokine Detection (Figure 5). Anti-TNF-alpha antibodies and anti-IFN-gamma antibodies were coated on a 96-well plate, and samples containing cytokines were tested by ELISA. The data are as shown in the figure (n=6).<\/p>\n\n\n\n Conclusion<\/strong><\/p>\n\n\n\n Introduction ELISA (enzyme-linked immunosorbent assay) […]<\/p>\n","protected":false},"featured_media":2570,"template":"","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"knowledge2_cat":[96],"knowledge2_app":[],"class_list":["post-2752","knowledge2","type-knowledge2","status-publish","has-post-thumbnail","hentry","knowledge2_cat-biji"],"yoast_head":"\n<\/figure>\n\n\n\n
\n
\n
<\/figure>\n\n\n\n
\n
\n
\n
\uff08\u7ade\u4e89\u6cd5ELISA\uff0c\u56fe3\uff09<\/li>\n\n\n\n\n
<\/figure>\n\n\n\n
\n
(\u78c1\u73e0\u5f0fELISA, \u56fe4)<\/li>\n\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
\n
\u597d\u3002<\/li>\n\n\n\n
\u5b9e\u73b0\u5168\u81ea\u52a8\u5316\u5904\u7406\uff0c\u4e14\u7ed3\u679c\u4e0e FDA \u8ba4\u8bc1\u7684 Elisa \u65b9\u6cd5\u6d4b\u5b9a\u7ed3\u679c\u4e00\u81f4\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"